Skip to content
  • Technology
  • Applications

    Clinical research

    • Cancer
    • Fibrosis
    • Inflammation
    • Ischemia
    • Lymphatic Disorders
    • Metabolic Disorders

    Preclinical research

    • Cancer
    • Fibrosis
    • Inflammation
    • Ischemia/Reperfusion
    • Metabolic Disorders
    • Neurological Disorders
    • Organ Dysfunction
  • Products

    Clinical research

    • MSOT Acuity
    • RSOM Explorer C50

    Preclinical research

    • MSOT inVision
    • RSOM Explorer P50
  • Resources
    • Publications
    • Webinars
    • Downloads
    • Login
  • About us
    • Careers
    • Contact
    • Events
    • News
  • Contact

Author: MKTG Associate

VEITHsymposium | VEITH 2023

14.11.2023 – 18.11.2023 // New York (USA)

Imaging in NMD | MYO-MRI 2023

5.11.2023 – 7.11.2023 // Berlin (Germany)

Vascular InterVentional Advances | VIVA 2023

30.10.2023 – 2.11.2023 // Las Vegas (USA)

World Muscle Society | WMS 2023

3.10.2023 – 7.10.2023 // Charleston (USA)

World Congress of Lymphology | ISL 2023

11.09.2023 – 15.09.2023 // Genova (Italy)

World Molecular Imaging Congress | WMIC 2023

5.09.2023 – 09.09.2023 // Prague (Czech Republic)

International Society for Experimental Microsurgery | ISEM 2023

22.06.2023 – 24.06.2023 // Genova (Italy)

Vascular Annual Meeting | VAM 2023

14.06.2023 – 17.06.2023 // National Harbor (USA)

Fast optoacoustic mesoscopy enables assessment of human melanoma microvasculature in vivo

In this webinar, Dr. Hailong He, Group leader at Technical University of Munich, presents his work on fast high-resolution optoacoustic imaging in human melanoma. He shows how 3D imaging of vascular characteristics in skin lesions could allow diagnostic insights not available by conventional visual inspection.

Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models

In this webinar, Dr. Isabel Quiros Gonzalez, Head of the Histopathology Core at the University of Oviedo and previously with Cancer Research UK Cambridge Institute, outlines her work using MSOT (multispectral optoacoustic tomography) to assess response to a vascular-disruptive treatment in a preclinical breast cancer model.

← older

Discover

  • Technology
  • Applications
  • Products

Resources

  • Downloads
  • Publications
  • Webinars
  • Login

About Us

  • Careers
  • Contact
  • Events
  • News
  • Data Privacy
  • Imprint

Leading the Field of Optoacoustic Imaging

iThera Medical GmbH
Zielstattstrasse 13
81379 Munich, Germany

© 2023 | All Rights Reserved